The morning after the world learned that a closely watched clinical trial of a coronavirus vaccine had been halted last week over safety concerns, the company’s chief executive disclosed that a person given the vaccine had experienced serious neurological symptoms.
Image: Pascal Soriot, chief executive of the drug company AstraZeneca, in Washington in February.Credit…Erin Schaff/The New York Times
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins.
Image: Illustration by Peter Greenwood for TIME – https://time.com
Don’t miss your change to be named the BioHealth Startup with the Most Commectial Potential at the BHCR Forum, win $10,000 and more!
Applications due: 9/24
Finalists notified by: 10/2
Mandatory presenter coaching for finalists: 10/7
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your complimentary virtual feedback session with BHI Entrepreneurs-in-Residence and Analysts on one of the following dates: 8/26. (45 minute blocks of time beginning at 9:00 in the morning. Pre-registration is required; sign up www.tinyurl.com/EIRFeedback. For questions/more information, contact BHI
Richmond, VA, Sept. 11, 2020 (GLOBE NEWSWIRE) — The Center for Innovative Technology (CIT) Board of Directors today announced Bob Stolle as the organization’s Chief Executive Officer and President of CIT. Stolle previously served as CIT’s Senior Vice President of Policy and Regional Initiatives as well as the head of CIT’s Entrepreneurial Ecosystems Division.
“Virginia’s entrepreneurship community has grown tremendously during Ed Albrigo’s tenure at CIT, and we are grateful for his dedicated service to our Commonwealth,” said Governor Ralph Northam. “I am pleased to welcome Bob Stolle to lead the agency and its efforts to advance our innovation economy.”
Image: The Center for Innovative Technology Announces Bob Stolle as Chief Executive Officer and President – https://www.globenewswire.com
ANNAPOLIS, Md. – Governor Larry Hogan today announced the acquisition of 250,000 rapid point-of-care antigen tests, which will be deployed to nursing homes, assisted-living facilities, and correctional and juvenile detention centers across the state. The purchase makes Maryland, the founding member of the bipartisan interstate testing compact with the Rockefeller Foundation, the first state in the compact to move forward with an order for rapid antigen tests.
Image: https://www.thebaynet.com
Seoul Office Will Be Opening to Develop Immunomic Therapeutics Investigational Cell Therapy for Brain Cancer
September 10, 2020 08:00 AM Eastern Daylight Time SEOUL–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, originating in the United States recently opened its first office in South Korea. This continues to build on ITI’s overall strategy to be the partner-of-choice for innovative biotechnology companies in emerging centers of excellence worldwide.
A 2016 decision to link the research labs at the University of Maryland College Park with those at the University of Maryland at Baltimore is paying dividends in the competition for federal COVID-19 research dollars, a top education official told a science advisory panel on Wednesday.
The decision was a spinoff of the University of Maryland Strategic Partnership Act, said Laurie Ellen Locasio, vice president for research at the two institutions.
We’re dedicated to helping cutting-edge innovators and leading investors connect. VSVC3 will be an engaging and immersive [live] interactive virtual summit providing startups the opportunity to gain the visibility they need and investors access to vetted deal flow.
TED Talks began in 1984 as a conference originating in Silicon Valley where powerful voices in Technology, Entertainment, and Design came together to spread potent ideas with broad relevance. Today there are thousands of talks of 18 minutes or less, in more than 100 languages, covering topics ranging from science to global issues. Despite this diversity, all TED talks share a devotion to Ideas Worth Spreading.
Image: https://www.americangene.com
